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Abstract. In bone forming cartilage in vivo, cells un-
dergo terminal differentiation, whereas most of the
cells in normal articular cartilage do not. Chondrocyte
hypertrophy can be induced also in vitro by diffusible
signals. We have identified growth factors or hormones
acting individually on 17-d chick embryo sternal chon-
drocytes cultured in agarose gels under strictly serum-
free conditions. Insulin-like growth factor I or insulin
triggered the first steps of chondrocyte maturation,
i.e., cell proliferation and increased matrix deposi-
tion while the chondrocytic phenotype was maintained.
However, cells did not progress to the hypertrophic
stage. Proliferation and stimulated collagen production
was preceded by a lag period, indicating that synthesis
C
ARTILAGE cells in situ modulate their phenotype in
response to environmental stimuli. Pluripotent mes-
enchYmal cellsdifferentiate into resting chondrocYtes
characterized by a moderate rate of synthesis of aggregating
proteoglycans and collagens 11, IX, and XI. Most of the cells
maintain this phenotype in joints where cartilage is per-
manent. During endochondral ossification in development,
growth, and repair of bones, however, resting chondrocytes
differentiate further. Initially, they proliferate and, later, they
become hypertrophic in that they drastically increase both
their volume and metabolic activity. Hypertrphic cells de-
posit large quantities ofextracellular matrix containing carti-
lage-specific proteoglycans and collagens including collagen
X, a marker for this stage ofdifferentiation (Schmid and Lin-
senmayer, 1985). In contrast to resting and proliferative
cartilage cells, hypertrophic cells also produce alkaline
phosphatase.
The phenotypicflexibility ofchondrocytes is also apparent
in vitro. In monolayer culture, the cells can gradually lose
the cartilage phenotype and begin to resemble mesenchymal
cells (Holtzer et al ., 1960) and they produce macro-
molecules not normally found in cartilage (Mayne et al.,
1976; von der Mark et al ., 1977). By contrast, in suspension
culture stabilized by semisolid gels (Horwitz and Dorfman,
1970), chondrocytes remain differentiated and cells modu-
lated in monolayer culture reexpress the cartilage phenotype
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of other components was required before cells became
responsive to insulin-like growth factor I or insulin.
Very small amounts of FBS exerted effects similar to
those of insulin-like growth factor I or insulin . How-
ever, FBS could act directly and elicited hypertrophy
when constituting >1% of the culture media. Basic
FGF has been claimed to be the most potent chondro-
cyte mitogen, but had negligible effects under serum-
free conditions. The same is true for PDGF, a major
serum-mitogen. Under the direction of thyroxine, cells
did not proliferate but became typical hypertrophic
chondrocytes, extensively synthesizing collagen X and
alkaline phosphatase.
in agarose (Benya and Shaffer, 1982) or collagen gels (Gib-
son et al., 1982) . These observations led to the conclusion
that cell-matrix interactions were responsible, at least in
part, for the program of gene expression in cartilage. An at-
tractive possibility for the mechanism of matrix-induced
effects on cells consists of indirect effects on signaling mole-
cules (Nathan and Sporn, 1991). In this concept, matrix
components may regulate cellular activitiesby binding growth
factors or hormones, thereby concentrating or inactivating
them. Degradation ofstationary components binding diffusi-
ble signals could well lead to an increased response by the
tissue.
Metabolic regulation in cartilage by growth factors has
been extensively studied in vivo or in organ or cell culture
(for reviews see Canalis et al., 1989; Humbel, 1990; Froesch
et al., 1985; Gospodarowicz, 1990; Massagu6, 1990; Hel-
din and Westermark, 1989; Ross et al ., 1986). However,
effects elicited in vivo are frequently difficult to attribute to
specific signaling molecules because systemic components
can interfere. Likewise, the interpretation of tissue culture
experiments is complicated because chondrocytes are fre-
quently kept in monolayer culture or in media containing se-
rum, or both. In addition, cultures have often been desig-
nated as serum-free, when the media contained very low
amounts of serum or when serum was removed only prior
to growth factor-treatment. For chondrocytes, this is partic-
1035Figure 1. Development of chick embryo sternal chondrocytes in vitro . Phase-contrast light micrographs of cells treated with FBS (A-C,
0.1% ; D-F, 1% ; G and H, 10Ró), 10 ng/ml of basic FGF (J), 50 ng/ml PDGF (K), or 100 ng/ml of IGF-I (L) . Control cells (I) were
grown in DME containing 1 mM cysteine, only. The culture periods were : 3 d (A, D, and G), 7 d (B, E, H, and L), and 14 d (C, F,
I, J, and K) . The same micrographic field is shown for each culture condition in A-H. Note that cells treated with either basic FGF or
PDGF are irregularly shaped and form small clusters (arrows in J and K) . Bar, 50 um .
ularly inappropriate because FBS by itself acts as a strong
￿
mation on insulin-like growth factor type I (IGF-I)', insu-
mitogen and can induce the entire cascade ofterminal differ-
￿
lin, basic FGF, PDGF, and thyroxine .
entiation (Bruckner et al ., 1989) .
Primary chondrocytes from 17-d-old chick embryo sterna
￿
Materials andMethods
maintain the resting phenotype in serum-free gel-suspension
culture. They are viable inDME containing pyruvate or cys-
￿
Agarose Cultures teine and, hence, chemically undefined culture media can be
avoided (Tschan et al ., 1990) . These culture conditions offer
￿
17-d-old chick embryo sternal chondrocytes were grown in serum-free
aunique opportunity to study the influence ofindividual sig-
￿
agarose suspension culture in 35-mm Petri dishes at a density of 2 x 10 6
naling molecules on both proliferation and induction of
hypertrophy in chondrocytes. Here, we provide such infor-
￿
1 . Abbreviation used in this paper : IGF-I, insulin-like growth factor type 1 .
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1036Table 1. Chondrocyte Proliferation in Response to FBS
Experiment 1
Experiment 2
The numbers represent the cell numbers observed in a particular microscopic
field after the culture period indicated divided by the numbers observed at day
1 in the same field.
cells/n-d as described(Tschan et al., 1990). Briefly, cells suspended in0.5
agarose in DME were seeded into dishes precoated with agarose gels and
were allowed to sediment to the interface between the agarose layers. The
upperagarose layercontaining the cells was thenallowedtosolidify by brief
exposure to 4°C (Benya and Shaffer, 1982). The mediumwas DMEcontain-
ing 1 mM cysteine. Where applicable, media also contained FBS, recom-
binant human IGF-I (a kind gift from Ciba Geigy AG, Basel, Switzerland),
recombinant human PDGF B/B (Boehringer Mannheim GmbH, Mann-
heim, FRG), recombinant bovine basic FGF (Progen GmbH, Heidelberg),
or thyroxine (Sigma Chemical Co., St. Louis, MO), respectively. All media
were replaced after every 2-3 d.
DeterminationofCellProliferation
Cells at the agarose interfaces were monitored by phase-contrast light mi-
croscopy. Several representative fields of each culture dish were followed
throughout the entire culture period and rates ofproliferation of at least 25
cells per fieldarbitrarily selected at thebeginning of the cultures were deter-
mined by direct counting on the micrographs.
SynthesisofCollagen andProteoglycans
Cultures were labeled with 1 WCi/ml of [U-"°Clproline (285 mCi/mmol;
Amersham International) for 3 d or with 2.5 pCi/ml of31SO4 (1.209 Ci/
mmol; Amersham International) for 24 h. Collagens were extracted from
whole cultures after digestion with pepsin (Serva, Heidelberg, FRG) as
reported (Benya and Shaffer, 1982). Precipitation ofthe extracts at neutral
pH with (NH)2SO4 at 45 % saturation or with 4 M NaCl yielded radiola-
beled peptides derived from collagens, only, as shown by SDS-PAGE (see
Fig. 2). Radiolabeled proteoglycans were extracted from whole cultures
with 4 M guanidinium hydrochloride, 10 mM EDTA, 50 mM sodium ace-
tate, pH 6.5, and quantified as described (Bruckner et al., 1989).
Table II. Collagen Synthesis as Determined
by Incorporation ofp4CJproline into
Pepsin-resistant Protein
Experiment 1
Experiment 2
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TableIII. Proteoggycan Synthesis Determinedby
Incorporation of s5Sp4 into Nondialyzable Material
The values indicated were obtained for duplicate dishes ofthe same cell prepa-
ration.
Determination ofAlkalinePhosphataseActivity
Whole cultures were extracted for 2 h at 4°C with 25 mM Tris-HCI, 1.25
mM MgC12, 0.2 mM PMSF, and 0.25% Triton X-100, pH 7.4. Agarose
was removed by centrifugation and alkaline phosphatase activity in the su-
pernatants was measured by the methodof Bessey et al. (1946). Briefly, the
kinetics of hydrolysis ofp-nitrophenyl phosphate in 1 M diethanolamine-
HCI, pH 9.8, by the extracts were monitored at 405 run.
For histochemical detectionofalkaline phosphatase-activity, 35-mm cul-
ture dishes were supplemented with 1 ml of 100 mM Tris-HCI, 100 mM
NaCl, 50 mM MgCl2, pH 9.5, containing 10 ul of 30 mg/ml Nitroblue-
tetrazolium (Sigma Chemical Co.) in 70% dimethylformamide and 10 wl
of 15 mg/ml 5-Bromo-4-chloro-3-indolyl-phosphat (X-phosphat; Boeh-
ringerMannheim) in DMF After 30 min in the dark at 37'C, cultures were
subjected to phase-contrast light microscopy.
Results
Proliferation of chick embryo sternal chondrocytes in sus-
pension culture in agarose was determined by counting ofin-
dividual cells in representative micrographs of the same
fields taken after various periods of time. As shown in Fig.
1, this method was easily applicable in early cultures up to
two weeks. In older cultures containing FBS, cells formed
clusters in which individual cells could not well be dis-
cerned.
FBS is not only a powerful mitogen for chick embryo ster-
nal chondrocytes but also induces their maturation. Hyper-
trophic chondrocytes appear after 7 d in culture with 10%
FBS (Bruckner et al., 1989; Tschan et al., 1990) . Here, we
determined the dose dependence of FBS on the stimulation
of cell proliferation and the synthesis of collagens and pro-
teoglycans. In contrast to serum-freeconditions, media with
only 0.1% of FBS activated proliferation (Table I) and depo-
sition of matrix macromolecules. In such cultures, the quan-
tities of newly synthesized collagens varied from experiment
to experiment but were at least five times larger than in
serum-free cultures (Table II). Proteoglycan synthesis was
less increased (Table III) . However, at these low concentra-
tions of FBS cells showed no distinct signs of hypertrophy.
They were only slightly enlarged in comparison to their ini-
tial size (Fig. 1, A-C) or to control cells (Fig. 11) and syn-
thesized neither collagen X (Fig. 2, lanes 1, 4, and 6) nor
alkaline phosphatase (Table IV) . The cells maintained this
state for at least 9 wk (not shown).
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FBS
0
3
0.85
Increase in cell
7
0.87
numbers at
10
1 .09
day
14
1 .03
0.1 0.83 1.04 1 .16 1 .20
1 0.90 1.27 1 .62 2.46
10 1 .61 1 .70 3 .30 2.38
0 1 .19 1 .15 1.10 1 .15
0.1 1 .05 1.71 1 .82 1 .97
1 1 .15 1.95 4.23 5.43
FBS 4
cpm/dish (x
7
10-') at day
14 24
0 12.920 16.940 17.440 15.960
18.415 17.550 19.180 14.208
0.1 27.599 77.000 18.720 28.560
19.306 44.750 21 .560 31 .640
1 35 .893 103.320 120.692 322.128
33 .020 82.460 95.715 322.420
10 99.120 302.330 381 .000 158.044
77.000 422.660 450.808 -
FBS
cpm/dish
7
(x 10-') at
14
day
21
0 1 .28 1 .90 1 .03
0.1 8.42 9.22 12 .56
1 62.64 71 .90 66.14
10 422.62 37.92 57 .04
0 0.76 1 .50 1 .55
0.1 8.12 27.48 23 .30
1 304.46 21 .08 30.64
10 626.82 252 .64 153 .66Figure 2. Fluorograph of pepsin-digested collagens metabolically labeled for 3 d with ['°C]proline, and subjected to SDS-PAGE (4.5-
15% gradient gel) . Cells were grown with 0.1% FBS (lanes 1, 4, and 6), 1% FBS (lanes 2, S, and 7) or 10% FBS (lane 3) for 7 d (lanes
1-3), 14 d (lanes 4 and 5), and 21 d (lanes 6 and 7) . Cells were cultured with 1 nm of thyroxine for 10 d (lanes 8 and 11), 100 ng/ml
of IGF-I for 10 d (lanes 9 and 12), 100 ng/ml of insulin for 10 d (lane 10), 1 ng/ml of basic FGF for 8 d (lane 14), or with 1 ng/ml of
PDGF for 8 d (lane 15) . Collagens synthesized by serum-free control cells pane 13) . Samples in lanes 11 and 12 were reduced with 2%
b-mercaptoethanol before electrophoresis .
When the serum content ofthe media was increased to 1 %,
cells not only proliferated (Table I), but eventually also be-
came hypertrophy. After 2 wk, they were distinctly larger
than control cells (Fig . 1, compareFand I) and transiently
produced larger amounts of matrix molecules. Most impor-
tantly, however, the cells produced collagen X increasingly
with time in culture (Fig . 2, lanes 2, 5, and 7) . As expected,
signs ofhypertrophy including expression of collagen X ap-
peared later than in cells exposed to 10% FBS (Fig . 2, lane
3) . In response to FBS, cells acquired a somewhat irregular
shape, the extent ofwhich depended on length of culture and
the amount of FBS (Fig. 1, C and F) .
To identify candidates among serum components respon-
sible for the effects described above, we studied growth fac-
tors and hormones in serum-free cultures . As a first exam-
ple, IGF-I was selected because it is a prominent growth
factor ofserum (Humbe1,1990), stimulates deposition ofex-
tracellular matrix in cartilage explants (Salmon and Daugha-
day, 1957), has been reported to promote proliferation in
chondrocytes in vitro in the presence ofFBS (Vetter et al .,
1989 ; Froger-Gaillard et al ., 1989 ; Trippel et al ., 1989), and
may substitute for growth hormone during development or
Table IV . Production ofAlkaline Phosphatase in Cultures
Treated with Serum, IGF-I, or Thyroxine
Enzymatic activity was measured as micromoles p-nitrophenol per minute per
dish liberated from p-nitrophenyl phosphate .
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growth ofhypophysectomized animals (Froesch et al ., 1990) .
IGF-I stimulated proliferation ofchondrocytes and increased
matrix production, albeit in a manner distinct from that of
FBS . Under the direction of 10-100 ng/ml of IGF-I, a range
of concentrations expected to exist in media containing 10%
FBS (Humbel, 1990), cell numbers increased about three-
fold after a lag period of 3-10 d, reaching plateau levels
around 14-20 d (Figs . 1 L and 3) . The exact time of onset
and of termination of cell proliferation varied between ex-
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Figure 3 Cell proliferation of chondrocytes under the direction of
10% FBS (o), 10 ng/ml (o) or 100 ng/ml of IGF-I (A), 100 ng/ml
ofinsulin (n), or 1 ng/ml ofthyroxine (e) . Control cells (0) . Light
micrographs were repetitively taken from the same field during the
experiments . The increase of cell numbers corresponds to the num-
ber of cells counted at the day indicated divided by the numbers ob-
served in the same field immediately after inocculation. Results of
a typical experiment are shown.
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Enzymatic activity at day
14 21
Serum-free culture 0.010 0.035 0.021
10% FBS 40.000 62.000 75.000
0.1% FBS 0.045 0.035 0.021
100 ng/ml IGF-I 0.011 0.070 0.021
100 nM Thyroxine ND 127.000 41 .0000
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Figure 4. Amount ofcollagens newly synthesizedby cells under the
influence of IGF-I . 10 ng/ml (o), 100 ng/ml (o), or 1 Ag/ml (n) .
Control (o) . Collagen production was determined by incorpora-
tion of radioactively labeled proline into pepsin resistant macro-
molecules (for details, see text) . Results of a typical experiment are
shown .
periments and closely correlated with the long-term viability
ofcontrol cells cultured without growth factors . Importantly,
however, the lag period was not observed in cells treated with
10% FBS (Fig . 3), demonstrating the capability of the cells
to proliferate immediately as a result of an appropriate
stimulus . IGF-I treatment led to a strong transient increase
in the level ofcollagen production (Fig . 4) . Interestingly, col-
lagen synthesis increased and subsided simultaneously with
cell proliferation (Fig . 5) . Cells exposed to IGF-I synthe-
sized collagens II, IX, and XI, but neither collagen X (Fig.
2) nor alkaline phosphatase (Table IV), even after long cul-
ture periods. In agreement with its early designation as sulfa-
tion factor, IGF-I augmented secretion ofproteoglycans (Fig.
6) in parallel with collagen production . Therefore, IGF-I did
not change the chondrocytic phenotype and, in contrast to
FBS, did not promote hypertrophy of chondrocytes derived
from whole 17-d chick embryo sterna .
days in culture
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Figure 5. Synchronized proliferation and collagen production of
cells under the influence of 10 ng/ml IGF-I . Production of pepsin-
resistant protein (e); cell proliferation (o) . Conditions were as de-
scribed for Figs . 3 and 4 .
Figure 6. Level ofproteoglycan synthesis in IGF-I treated cells . The
amount of newly synthesized proteoglycans was determined as
35SO4 incorporated into nondialyzable material extracted from
cultures with 4M guanidinitnn chloride . (Shaded columns) 10 ng/
ml ; (hatched columns) 100 ng/ml ; (filled columns) 1 iAg/ml ; (open
columns) control cells.
Because of the partial cross-reactivity of insulin with the
receptor of IGF-I, we predicted that it could mimic IGF-I-
activity at 10-100 times larger concentrations. As shown in
Fig . 3, however, insulin and IGF-1 induced proliferation at
similar concentrations . Collagen synthesis was stimulated by
100 ng/ml of insulin and occurred at elevated levels even af-
ter cell proliferation ceased (Fig . 7) . We concluded that insu-
lin acted primarily via its own receptor rather than that of
IGF-I . Collagens II, IX, and XI, but not collagen X, were
secreted in response to 100 ng/ml of insulin (Fig. 2, lane 10) .
Basic FGF has been designated as the most potent chon-
drocyte mitogen in vitro (Kato et al ., 1987) . In addition,
Iwamoto et al . (1991) recently reported that basic FGF in-
hibited chondrocyte hypertrophy in culture . In the present in-
vestigation, basicFGF without serum was a very poor mito-
gen . Instead, the cells only slightly changed their shape after
2 wk in the presence of 0.1-10 ng/ml of this growth factor
(Fig . 1 J), but neither proliferated (Fig. 1, compare I and J)
nor generated more collagen than control cells (Fig . 2, com-
pare lanes 13 and 14) . The pattern of collagen expression re-
mained unchanged (Fig . 2, lane 14) . In conjunction with
10% FBS, basic FGF stimulated colony formation of cells
at an initial density of 2 x 104 cells/ml (not shown) as
reported (Kato et al., 1987) .
PDGF accounts for a large fraction ofthe mitogenic activ-
ity of serum (Ross et al ., 1986) and chondrocytes express
receptors for PDGF (Bowen-Pope et al ., 1985) . Under the
present culture conditions, this factor did not promote cell
division, matrix synthesis, or chondrocyte hypertrophy .
Results closely comparable to those with basic FGF were
obtained with 1-100 ng/ml ofPDGF (Fig . 1 K and Fig . 2,
lane 15) .
Thyroxine has wellknown effects on skeletal development .
In man, chronically low levels of thyroxine during fetal de-
velopment and in infancy are associatedwith growth retarda-
tion (skeletal cretinism) and elevated levels with accelerated
skeletal development (Schlesinger and Fisher, 1951) . Fur-
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Figure 7 . Collagen production under the control of 100 ng/ml of in-
sulin (o) or 100 ng/ml ofIGF-I (o) . Experimental conditions were
as described in Fig . 4 . Note : Collagen synthesis continues at ele-
vated level in cells treated with insulin but not IGF-I after cessation
of cell division .
thermore, the hormone has been reported to support chon-
drogenic expression in monolayer cultures (Pawelek, 1969) .
Under our conditions, thyroxine affected remarkably the
phenotype of chondrocytes in vitro. When the media con-
tained 1-100nM of the hormone, cells decreased in numbers
(Fig . 3), but drastically increased their size between day 7
and 14 in culture (Fig . 8 A) . Strikingly, the pattern of newly
synthesized collagens also included collagen X (Fig . 2, lanes
8and 11) . Consistent with the behavior ofhypertrophic chon-
drocytes, some ofthe cells secreted large amounts ofalkaline
phosphatase (Table IV) conspicuously associated with ma-
trix vesicles (Fig . 8 A) .
The cells used in this study were derived from entire 17-d
chick embryo sterna and, therefore, represented a hetero-
geneous population of resting, proliferating, and, possibly,
early hypertrophic chondrocytes . However, fully mature
chondrocytes synthesizing collagen X and alkaline phospha-
tase were absent since they appear in the organ only at day
18 (LuValle et al ., 1989) . Because the tissue surrounding the
sterna can easily be removed, cells other than chondrocytes
were also not present . Our isolation and culture protocols
(Tschan et al ., 1990) yielded at least 85% viable cells with
properties similar to those in situ at the beginning of the cul-
ture experiments . We have employed this cell population as
a tool to identify agents involved in the induction of chondro-
cyte hypertrophy. Because our cultures contained cells at
different stages preceding hypertrophy we anticipated that,
at least in a part ofthe cells, extracellular signals would have
elicited responses if they played a role in terminal chondro-
cyte differentiation in situ .
The mitogenic activity ofFBS remained unmatched by all
agents tested . Very small amounts of serum triggered cell di-
vision, underscoring again the necessity of serum-free cul-
ture conditions in studies on regulatory effects of extracellu-
lar signals on chondrocytes . Hypertrophy, however, is not
induced at very low levels of FBS even after long culture
periods . A striking variability of the proliferative and meta-
Figure 8 . Phase-contrast micrographofcultures stained for alkaline
phosphatase-activity. (A) Cells treated with 1 rim thyroxine for
12 d. Note : Matrix vesicles are heavily stained. (B) Control cells.
Bar, 25 /,m .
bolic responses of the cells toFBS was observed between ex-
periments . The reason for this is unknown, butmay well re-
sult from the complexity of cellular responses to the diverse
mixtures ofsignaling molecules in FBS, further emphasizing
the need for strictly controlled culture conditions in studies
on environmental regulation of cell functions . In our earlier
studies, we have described culture conditions for resting or
hypertrophic chondrocytes (Bruckner et al ., 1989 ; Tschan et
al ., 1990) . Here, we have established conditions for the
maintenance of cells resembling those of the proliferative
zone of developing long bones or the sternum of chick em-
bryos .
IGF-I and insulin were mitogenic to chondrocytes in-
dependently from each other. In both cases, no additional
factors were required . In response to IGF-I at physiological
or lower concentrations, cell numbers reached the same pla-
teau level as in the presence of 10% FBS . This is consistent
with the notion that IGF-I was a major serum-mitogen for
chondrocytes . However, IGF-I and 10% FBS differed from
each other in that proliferation was induced by IGF-I only
after a lag period . We concluded that proliferation stimu-
lated by FBS does not result from the exclusive action of
IGF-I . In addition, chondrocytes probably became sensitive
to IGF-I only through synthesis of additional components .
1040Likely candidates include synergistic growth factors, IGF-
binding proteins (Sara and Hall, 1990), or matrix compo-
nents. It is also possible that IGF-I-receptors enzymatically
removed from cell surfaces during preparation were recon-
stituted during the lag period.
In contrast to IGF-I or insulin, basic FGF and PDGF nei-
ther promoted cell division nor matrix production nor hyper-
trophy in serum-free cultures ofchondrocytes. However, ba-
sic FGF bolstered the mitogenic activity of FBS in cultures
with low cell densities, indicating that the cellsbecame con-
ditioned by FBS so that they could respond to basic FGR It
is probable, however, that chick embryo sternal chondro-
cytes in situ are not sensitive towards basic FGF. Indeed, ba-
sic FGF acted only on injured cartilage in vivo where it could
elicit repair but was inactive towards intact tissue (Cuevas et
al., 1988) .
Thyroxine at or below concentrations found in normal
chicken plasma (Scanes et al., 1989) proved to be a strong
initiator of chondrocyte hypertrophy. Preliminary results
suggested that triiodothyronine had a similar activity. Again,
no synergism with other components was needed. These ob-
servations were predicted by the study ofBurch and Lebovitz
(1982a,ó) reporting that triodothyronine and thyroxine stim-
ulated growth and maturation of embryonic chick cartilage
in serum-freeorganculture. The presence of collagen X pro-
duced by our cells treated with thyroxine definitively cor-
roborates this notion. However, our conclusions differ from
those of Kavumpurath and Hall (1990) who did not find
chondrocyte hypertrophy in embryonic chick Meckel's carti-
lage in response to thyroxine. Because hypertrophic chon-
drocytes in mammalian growth plates always originate from
cells that have previously proliferated in columnar patterns,
it has been assumed that proliferation was a necessary step
preceding terminal differentiation . Support for this concept
has also come from in vitro studies on chondrocyte matura-
tion (Castagnola et al., 1988; Quarto et al ., 1990) . However,
in secondary centers of ossification, chondrocytes normally
proceed towards hypertrophy without extensive prolifera-
tion. Depending on the culture conditions, our in vitro sys-
tem is strikingly capable to duplicate both pathways of en-
dochondral ossification in vivo. In response to thyroxine,
cell proliferation was not required prior to terminal differen-
tiation.
Hypertrophy ofchondrocytes is a normal process in growth
plates where mature cells prepare the tissue for ossification.
By contrast, terminal differentiation of chondrocytes result-
ing in the production of collagen X occurs at low level and
only in deep zones of normal articular cartilage where the
tissue is permanent (Gannon et al., 1991). However, in de-
generative joint disease, brood capsules ofproliferating cells
are found near fissures at delaminating articular surfaces
(Sokoloff, 1979). Interestingly, collagen X is also present at
highly elevated level in such tissue (von der Mark and Gldck-
ert, 1990) indicating thatpathologically altered articular car-
tilage has acquired the ability to respond to stimuli initiating
terminal chondrocyte differentiation. It is tempting to specu-
late that some of the signaling molecules studied here may
play an important role not only in endochondral bone forma-
tion but also in degenerative joint diseases.
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